The pandemic has magnified issues of gender equity that permeate medicine. Can it also be the catalyst for real change?
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Findings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not.
Stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.
Vaccines and other policies could help keep in check a disease that’s becoming increasingly common worldwide.
Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.
The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.